|
(AFX UK Focus)
2008-03-05 07:32
Teva files suit against FDA to relist generic risperdal |
|---|
| Article layout: raw |
|
Teva will argue that the FDA's decision to deny the period of exclusivity for the company's pending abbreviated new drug application for risperidone tablets, was unlawful. Risperdal is an antipsychotic medication used to treat schizophrenia and manic states associated with bipolar disorder. tf.TFN-Europe_newsdesk@thomson.com lam/cw
COPYRIGHT Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News. |
| Production or sales statistics Government regulatory actions |
| Article layout: raw |
|